Your browser doesn't support javascript.
loading
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.
Gersekowski, Kate; Na, Renhua; Alsop, Kathryn; Delahunty, Rachel; Goode, Ellen L; Cunningham, Julie M; Winham, Stacey J; Pharoah, Paul D P; Song, Honglin; Webb, Penelope M.
Afiliación
  • Gersekowski K; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Na R; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Alsop K; University of Queensland, School of Public Health, Brisbane, Queensland, Australia.
  • Delahunty R; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Goode EL; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Cunningham JM; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Winham SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Pharoah PDP; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Song H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Webb PM; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Cancer Epidemiol Biomarkers Prev ; 33(4): 586-592, 2024 Apr 03.
Article en En | MEDLINE | ID: mdl-38300121
ABSTRACT

BACKGROUND:

Women with an inherited pathogenic variant in BRCA1 or BRCA2 have a greatly increased risk of developing ovarian cancer, but the importance of behavioral factors is less clear. We used a case-only design to compare the magnitude of associations with established reproductive, hormonal, and lifestyle risk factors between BRCA mutation carriers and noncarriers.

METHODS:

We pooled data from five studies from the Ovarian Cancer Association Consortium including 637 BRCA carriers and 4,289 noncarriers. Covariate-adjusted generalized linear mixed models were used to estimate interaction risk ratios (IRR) and 95% confidence intervals (CI), with BRCA (carrier vs. noncarrier) as the response variable.

RESULTS:

IRRs were above 1.0 for known protective factors including ever being pregnant (IRR = 1.29, 95% CI; 1.00-1.67) and ever using the oral contraceptive pill (1.30, 95% CI; 1.07-1.60), suggesting the protective effects of these factors may be reduced in carriers compared with noncarriers. Conversely, the IRRs for risk factors including endometriosis and menopausal hormone therapy were below 1.0, suggesting weaker positive associations among BRCA carriers. In contrast, associations with lifestyle factors including smoking, physical inactivity, body mass index, and aspirin use did not appear to differ by BRCA status.

CONCLUSIONS:

Our results suggest that associations with hormonal and reproductive factors are generally weaker for those with a pathogenic BRCA variant than those without, while associations with modifiable lifestyle factors are similar for carriers and noncarriers. IMPACT Advice to maintain a healthy weight, be physically active, and refrain from smoking will therefore benefit BRCA carriers as well as noncarriers.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 / Proteína BRCA2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína BRCA1 / Proteína BRCA2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos